Scientists track Long-Term safety of pioneering hepatitis b gene therapy
NCT ID NCT07254208
Summary
This study aims to monitor the long-term safety of an experimental gene-editing treatment called PBGENE-HBV in people with chronic hepatitis B. It will follow 45 participants who received the treatment in a previous trial, checking for any delayed side effects. No new treatment is given in this follow-up study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HBV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.